Literature DB >> 22926113

Guidelines for predicting performance with low vision AIDS.

Keziah Latham1, Daryl R Tabrett.   

Abstract

PURPOSE: To determine predictors of success in reading with low vision aids, in terms of reading acuity, optimum acuity reserve, and maximum reading speed, for observers with vision loss from various causes.
METHODS: One hundred people with vision loss affecting their daily lives participated. Clinical visual function measurements of distance acuity, contrast sensitivity, binocular threshold visual fields, and near reading performance with a MNRead chart at 40 cm were obtained. Reading performance aided by habitual low vision aids was also assessed with a MNRead chart.
RESULTS: Aided reading acuity was best predicted by clinical reading acuity and contrast sensitivity. For most observers, a 2:1 acuity reserve was sufficient to achieve near-maximum reading speed, but one-third of observers with aided reading acuity better than 1.2 M required a higher acuity reserve. Aided maximum reading speed was best predicted by clinically assessed reading speed and by clinical reading acuity.
CONCLUSIONS: People with vision impairment are likely to achieve 1 M with a low vision aid if their clinically assessed reading acuity is better than 0.85 logMAR. If acuity is worse than this, but contrast sensitivity is better than 1.05 logCS, 1M is also likely to be achieved. A 2:1 acuity reserve is adequate for 75% of observers, but those with good aided reading acuity may require further magnification to achieve best reading speeds. Fluent reading (>80 words per minute) is likely to be achieved if an observer reads fluently with large print at a fixed working distance and if clinically assessed reading acuity is better than 1.0 logMAR.

Entities:  

Mesh:

Year:  2012        PMID: 22926113     DOI: 10.1097/OPX.0b013e31825bff1c

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  9 in total

1.  Comparison of LogMAR Eye charts with angular vision for visually impaired: the Berkeley rudimentary vision test vs LogMAR One target Landolt ring Eye chart.

Authors:  Marie Miwa; Masaki Iwanami; Mari S Oba; Nobuhisa Mizuki; Tomomi Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-09-22       Impact factor: 3.117

2.  New challenges in low-vision research.

Authors:  Susana T L Chung; Ian L Bailey; Gislin Dagnelie; Jonathan A Jackson; Gordon E Legge; Gary S Rubin; Joanne Wood
Journal:  Optom Vis Sci       Date:  2012-09       Impact factor: 1.973

Review 3.  Prentice medal lecture 2013: visual accessibility: a challenge for low-vision research.

Authors:  Gordon E Legge
Journal:  Optom Vis Sci       Date:  2014-07       Impact factor: 1.973

4.  Visual, Musculoskeletal, and Balance Complaints in AMD: A Follow-Up Study.

Authors:  Christina Zetterlund; Hans Olof Richter; Lars-Olov Lundqvist
Journal:  J Ophthalmol       Date:  2016-10-18       Impact factor: 1.909

5.  Rate of Parental Consanguineous Marriage among Patients with Visual Impairments in Turkey.

Authors:  Sezen Akkaya
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2016

6.  The Effect of Magnification and Contrast on Reading Performance in Different Types of Simulated Low Vision.

Authors:  Michael Christen; Mathias Abegg
Journal:  J Eye Mov Res       Date:  2016-02-28       Impact factor: 0.957

7.  Repeatability and Validity of MNREAD Test in Children With Vision Impairment.

Authors:  Dawn K DeCarlo; Liyan Gao; Gerald McGwin; Cynthia Owsley; MiYoung Kwon
Journal:  Transl Vis Sci Technol       Date:  2020-12-16       Impact factor: 3.283

Review 8.  Revisiting Vision Rehabilitation.

Authors:  Claire Meyniel; Bahram Bodaghi; Pierre-Yves Robert
Journal:  Front Syst Neurosci       Date:  2017-11-01

9.  Contrast Sensitivity Is a Significant Predictor of Performance in Rifle Shooting for Athletes With Vision Impairment.

Authors:  Peter M Allen; Rianne H J C Ravensbergen; Keziah Latham; Amy Rose; Joy Myint; David L Mann
Journal:  Front Psychol       Date:  2018-06-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.